UC Ultralife CORP Stock: price and insider trades · United States · SEC (Form 4)Track the Ultralife CORP stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Operating in the Industry sector, Ultralife CORP has logged 57 public disclosures. Market capitalisation: €86.4m. The latest transaction was disclosed on 16 March 2026 (Acquisition). Among the most active insiders: WHITMORE BRADFORD T. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,204 of 29,063 companies
FCF yld 8.2%
Earn yld -6.8%
EV/EBITDA ·
ROE -6.2%
Gross mgn 24%
Net mgn -3.1%
Debt/EBITDA ·
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 March 2026
All Executives57 Thresholds0 Prospectus0 Other0
Declarations 57 total
▲ Director · Executives · 12 Mar 2026
33,741 shares @ US$5.9663 0.18% mcap 11.8% of flow Common Stock SEC:0000933430-26-000002:0
Canonical exit: 10 Jun 2026 (T+90) ▲ President and CEO · Executives · 12 Mar 2026
1,800 shares @ US$6.01 5.9% of flow Ultralife Common Stock; $.10 par value SEC:0001437749-26-008418:0
Canonical exit: 10 Jun 2026 (T+90) ▲ Director · Executives · 12 Dec 2025
9,530 shares @ US$5.6257 0.048% mcap 3.1% of flow Common Stock SEC:0000933430-25-000011:0
Canonical exit: 12 Mar 2026 (T+90) ▲ Director · Executives · 15 Dec 2025
1,739 shares @ US$5.75 18.0% of flow Common Stock; $.10 par value SEC:0001437749-25-037844:0
Canonical exit: 15 Mar 2026 (T+90) ▲ Director · Executives · 24 Nov 2025
1,750 shares @ US$5.67 10.8% of flow Common Stock; $.10 par value SEC:0001437749-25-036397:0
Canonical exit: 22 Feb 2026 (T+90) ▲ Director · Executives · 19 Nov 2025
53,900 shares @ US$4.9706 11.8% of flow Common Stock SEC:0000933430-25-000010:0
Canonical exit: 17 Feb 2026 (T+90) ▲ President and CEO · Executives · 19 Nov 2025
1,000 shares @ US$4.943 2.6% of flow Common Stock; $.10 par value SEC:0001437749-25-035716:0
Canonical exit: 17 Feb 2026 (T+90) ▲ Director · Executives · 19 Aug 2025
15,898 shares @ US$6.5648 0.094% mcap 6.0% of flow Common Stock SEC:0000933430-25-000009:0
Canonical exit: 17 Nov 2025 (T+90) ▲ Director · Executives · 13 Jun 2025
1,548 shares @ US$7.68 26.5% of flow Common Stock; $.10 par value SEC:0001437749-25-020305:0
Canonical exit: 11 Sept 2025 (T+90) ▲ Director · Executives · 13 Jun 2025
10,000 shares @ US$7.6392 3.8% of flow Common Stock SEC:0000933430-25-000006:0
Canonical exit: 11 Sept 2025 (T+90) ▲ Director · Executives · 23 May 2025
11,980 shares @ US$5.4072 2.9% of flow Common Stock SEC:0000933430-25-000003:0
Canonical exit: 21 Aug 2025 (T+90) ▲ Director · Executives · 13 May 2025
8,957 shares @ US$5.3983 1.9% of flow Common Stock SEC:0000933430-25-000002:0
Canonical exit: 11 Aug 2025 (T+90) ▲ Director · Executives · 14 May 2025
4,000 shares @ US$5.49 23.3% of flow Common Stock; $.10 par value SEC:0001437749-25-016753:0
Canonical exit: 12 Aug 2025 (T+90) ▲ Director · Executives · 14 May 2025
5,000 shares @ US$5.44 22.0% of flow Common Stock; $.10 par value SEC:0001437749-25-016888:0
Canonical exit: 12 Aug 2025 (T+90) ▲ President and CEO · Executives · 13 May 2025
3,000 shares @ US$5.29 9.4% of flow Common Stock; $.10 par value SEC:0001437749-25-016413:0
Canonical exit: 11 Aug 2025 (T+90) ▲ President and CEO · Executives · 21 Nov 2024
1,500 shares @ US$7.245 6.9% of flow Common Stock; $.10 par value SEC:0001437749-24-035916:0
Canonical exit: 19 Feb 2025 (T+90) ▲ Director · Executives · 12 Nov 2024
2,500 shares @ US$7.91 22.0% of flow Common Stock; $.10 par value SEC:0001437749-24-034590:0
Canonical exit: 10 Feb 2025 (T+90) ▲ Director · Executives · 7 Jun 2024
1,397 shares @ US$10.91 49.2% of flow Common Stock; $.10 par value SEC:0001437749-24-019604:0
Canonical exit: 5 Sept 2024 (T+90) ◇ CFO and Treasurer · Executives · 17 Apr 2024
7,179 shares @ US$5.7075 49.3% of flow Common Stock; $.10 par value SEC:0001437749-24-012544:0
▲ President and CEO · Executives · 13 Mar 2024
1,000 shares @ US$8.60 5.2% of flow ULBI Common Stock; $.10 par value SEC:0001437749-24-007608:0
Canonical exit: 11 Jun 2024 (T+90) ◇ President and CEO · Executives · 27 Dec 2023
5,059 shares @ US$5.3057 16.2% of flow ULBI Common Stock; $.10 par value SEC:0001437749-23-035549:0
▲ Director · Executives · 6 Dec 2023
8,877 shares @ US$6.8271 2.5% of flow Common Stock SEC:0000933430-23-000017:0
Canonical exit: 5 Mar 2024 (T+90) ▲ Director · Executives · 27 Nov 2023
3,200 shares @ US$7.1196 0.9% of flow Common Stock SEC:0000933430-23-000016:0
Canonical exit: 25 Feb 2024 (T+90) ▲ President and CEO · Executives · 10 Nov 2023
500 shares @ US$7.43 2.3% of flow Common Stock; $.10 par value SEC:0001437749-23-031457:0
Canonical exit: 8 Feb 2024 (T+90) ▲ Director · Executives · 30 Oct 2023
10,171 shares @ US$7.0362 3.0% of flow Common Stock SEC:0000933430-23-000014:0
Canonical exit: 28 Jan 2024 (T+90) 25 of 57 declarations
Load more (32 remaining) 关于 Ultralife CORP Ultralife Corp. (股票代码: ULBI) 是一家在美国纳斯达克全球市场上市的美国工业公司。该公司为政府、国防、工业和商业客户开发和制造关键任务电池以及射频电源和通信解决方案。其公司总部位于纽约纽瓦克,在那里它还拥有主要的运营和制造基地。该公司现代起源可追溯到 1991 年,当时它从柯达 Ultra Technologies 部门的电池业务中独立上市。自那时以来,Ultralife 通过内部开发和有针对性的收购相结合的方式不断扩张。
Ultralife 将其业务分为两个核心部门:电池和能源产品以及通信系统。电池和能源产品包括锂 9 伏、圆柱形、薄型电池和其他不可充电电池,以及可充电电池、不间断电源、充电系统和相关配件。通信系统涵盖射频放大器、电源、电缆和连接器组件、放大扬声器、设备支架、箱体设备、便携式系统、用于固定和车载应用的集成通信系统以及系统工程服务。这种产品组合使 Ultralife 处于一个专业利基市场,而不是商品电池市场,其收入与技术应用相关,在这些应用中,可靠性、性能和定制工程比单纯的价格更重要。
从竞争角度来看,该公司将自己定位为一家具有强大工程能力、应用特定定制以及跨电源和通信终端市场多元化产品组合的关键任务解决方案提供商。它通过在多个地区拥有开发和制造资源,为北美、欧洲和亚洲的客户提供服务。该公司还以 Ultralife、Accutronics、Electrochem、Excell 和 SWE 等多个品牌销售产品。
最近的战略发展至关重要。2024 年 10 月,Ultralife 完成了对 Electrochem Solutions 的收购,增强了其电池制造能力,并扩大了其在能源、军事和工业应用领域的业务。在其 2025 年年度报告中,管理层表示已将多个亚硫酰氯/石油和天然气业务整合到电池和能源产品部门的一个业务中,以优化协同效应并深化客户参与。该公司还报告称,截至 2025 年底,积压订单约为 110 million 美元,环比增长,这表明近期可见性有所改善,订单流更强劲。
对于投资者而言,ULBI 仍然是一个利基工业名称,在国防、特种储能和通信系统领域拥有重要的业务。该业务高度依赖合同时间、产品组合和执行,但其以收购为主导的扩张和积压订单的增长表明,该公司正在寻求随着时间的推移扩大规模并提高盈利能力。